Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Chemed Q2 Adj. EPS $4.27 Misses $5.08 Estimate, Sales $618.80M Miss $634.03M Estimate

Author: Benzinga Newsdesk | July 29, 2025 03:17pm
Chemed (NYSE:CHE) reported quarterly earnings of $4.27 per share which missed the analyst consensus estimate of $5.08 by 15.86 percent. This is a 21.94 percent decrease over earnings of $5.47 per share from the same period last year. The company reported quarterly sales of $618.80 million which missed the analyst consensus estimate of $634.03 million by 2.40 percent. This is a 3.85 percent increase over sales of $595.88 million the same period last year.

Posted In: CHE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist